IFG Advisory LLC bought a new position in shares of MetLife, Inc. (NYSE:MET – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,180 shares of the financial services provider’s stock, valued at approximately $230,000.
Several other large investors also recently bought and sold shares of MET. Center for Financial Planning Inc. purchased a new stake in shares of MetLife in the 3rd quarter valued at $25,000. Eagle Bay Advisors LLC purchased a new stake in shares of MetLife in the 2nd quarter valued at $28,000. First Personal Financial Services purchased a new stake in shares of MetLife in the 3rd quarter valued at $30,000. Legend Financial Advisors Inc. purchased a new stake in shares of MetLife in the 3rd quarter valued at $30,000. Finally, SJS Investment Consulting Inc. purchased a new stake in shares of MetLife in the 3rd quarter valued at $31,000. Hedge funds and other institutional investors own 88.15% of the company’s stock.
MetLife Stock Performance
NYSE:MET opened at $60.62 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.13 and a current ratio of 0.13. The company has a fifty day moving average of $64.07 and a two-hundred day moving average of $68.80. The stock has a market capitalization of $46.94 billion, a PE ratio of 20.69, a P/E/G ratio of 0.54 and a beta of 1.05. MetLife, Inc. has a fifty-two week low of $52.83 and a fifty-two week high of $77.36.
Insider Activity
In other news, EVP Bill Pappas sold 11,345 shares of the stock in a transaction dated Monday, February 27th. The shares were sold at an average price of $71.96, for a total value of $816,386.20. Following the completion of the sale, the executive vice president now directly owns 46,231 shares in the company, valued at $3,326,782.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.26% of the company’s stock.
Analysts Set New Price Targets
MET has been the subject of several analyst reports. StockNews.com initiated coverage on shares of MetLife in a research note on Thursday, March 16th. They issued a “hold” rating for the company. Barclays decreased their target price on shares of MetLife from $83.00 to $79.00 and set an “overweight” rating for the company in a research note on Wednesday. Morgan Stanley decreased their target price on shares of MetLife from $90.00 to $80.00 and set an “overweight” rating for the company in a research note on Wednesday. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $77.00 to $80.00 and gave the company an “overweight” rating in a research note on Friday, January 6th. Finally, Wells Fargo & Company decreased their target price on shares of MetLife from $84.00 to $72.00 and set an “overweight” rating for the company in a research note on Wednesday, April 5th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $77.09.
MetLife Profile
MetLife, Inc provides insurance and financial services to individual and institutional customers. It offers life insurance, annuities, automobile and homeowner’s insurance and retail banking services to individuals as well as group insurance, reinsurance and retirement and savings products and services.
See Also
- Get a free copy of the StockNews.com research report on MetLife (MET)
- MarketBeat Week in Review – 4/10 – 4/14
- What is an IRA Account? All About IRAs
- Investing in Quantum Computing: A Guide
- Earnings Beat Proves Citigroup to be The Cheaper Bank Stock
- How to Invest in an IRA in 7 Simple Steps
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.